Press Releases News Year None202020192018201720162015201420132012 Ophthotech Corporation to Report First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018 May 01, 2018 | Ophthotech to Present at the Cowen and Company 38th Annual Health Care Conference Mar 06, 2018 | Ophthotech Reports Fourth Quarter and Full Year 2017 Financial and Operating Results Feb 27, 2018 | Ophthotech Targets Gene Therapy to Expand its Orphan and Age-Related Retinal Disease Strategy Feb 27, 2018 | Ophthotech Corporation to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Tuesday, February 27, 2018 Feb 21, 2018 | Ophthotech Announces First Patient Enrolled in the Phase 2b Clinical Trial of Zimura®, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1) Jan 16, 2018 | Ophthotech Announces Election of Jane Pritchett Henderson, Chief Financial Officer and Senior Vice President of Corporate Development at Voyager Therapeutics, to Its Board of Directors Jan 16, 2018 | Ophthotech Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference Jan 02, 2018 | Ophthotech Reports Third Quarter 2017 Financial and Operating Results Nov 08, 2017 | Ophthotech Corporation to Report Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017 Oct 30, 2017 | Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page next › Last page last »
Ophthotech Corporation to Report First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018 May 01, 2018 |
Ophthotech Targets Gene Therapy to Expand its Orphan and Age-Related Retinal Disease Strategy Feb 27, 2018 |
Ophthotech Corporation to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Tuesday, February 27, 2018 Feb 21, 2018 |
Ophthotech Announces First Patient Enrolled in the Phase 2b Clinical Trial of Zimura®, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1) Jan 16, 2018 |
Ophthotech Announces Election of Jane Pritchett Henderson, Chief Financial Officer and Senior Vice President of Corporate Development at Voyager Therapeutics, to Its Board of Directors Jan 16, 2018 |
Ophthotech Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference Jan 02, 2018 |
Ophthotech Corporation to Report Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017 Oct 30, 2017 |
Press Releases News Year None202020192018201720162015201420132012 Ophthotech Corporation to Report First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018 May 01, 2018 | Ophthotech to Present at the Cowen and Company 38th Annual Health Care Conference Mar 06, 2018 | Ophthotech Reports Fourth Quarter and Full Year 2017 Financial and Operating Results Feb 27, 2018 | Ophthotech Targets Gene Therapy to Expand its Orphan and Age-Related Retinal Disease Strategy Feb 27, 2018 | Ophthotech Corporation to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Tuesday, February 27, 2018 Feb 21, 2018 | Ophthotech Announces First Patient Enrolled in the Phase 2b Clinical Trial of Zimura®, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1) Jan 16, 2018 | Ophthotech Announces Election of Jane Pritchett Henderson, Chief Financial Officer and Senior Vice President of Corporate Development at Voyager Therapeutics, to Its Board of Directors Jan 16, 2018 | Ophthotech Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference Jan 02, 2018 | Ophthotech Reports Third Quarter 2017 Financial and Operating Results Nov 08, 2017 | Ophthotech Corporation to Report Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017 Oct 30, 2017 | Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page next › Last page last »
Ophthotech Corporation to Report First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018 May 01, 2018 |
Ophthotech Targets Gene Therapy to Expand its Orphan and Age-Related Retinal Disease Strategy Feb 27, 2018 |
Ophthotech Corporation to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Tuesday, February 27, 2018 Feb 21, 2018 |
Ophthotech Announces First Patient Enrolled in the Phase 2b Clinical Trial of Zimura®, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1) Jan 16, 2018 |
Ophthotech Announces Election of Jane Pritchett Henderson, Chief Financial Officer and Senior Vice President of Corporate Development at Voyager Therapeutics, to Its Board of Directors Jan 16, 2018 |
Ophthotech Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference Jan 02, 2018 |
Ophthotech Corporation to Report Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017 Oct 30, 2017 |
